| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -13.00K | 2.98M | 1.49M | 138.47M | 548.82M | 624.58M |
| Gross Profit | -1.43M | 1.53M | 19.00K | -19.32M | 12.93M | 125.31M |
| EBITDA | -31.63M | 31.42M | -1.35M | -41.20M | -98.77M | -32.03M |
| Net Income | -45.45M | -54.30M | -29.16M | -94.56M | -217.05M | -140.13M |
Balance Sheet | ||||||
| Total Assets | 490.78M | 544.77M | 545.21M | 615.27M | 677.04M | 968.65M |
| Cash, Cash Equivalents and Short-Term Investments | 18.54M | 18.23M | 17.58M | 885.24K | 457.97K | 24.58M |
| Total Debt | 724.02M | 774.02M | 724.02M | 763.68M | 691.54M | 658.77M |
| Total Liabilities | 822.42M | 869.80M | 815.93M | 856.83M | 824.23M | 899.03M |
| Stockholders Equity | -331.65M | -325.02M | -270.72M | -241.56M | -147.19M | 69.62M |
Cash Flow | ||||||
| Free Cash Flow | 51.43M | -51.60M | 38.81M | -53.25M | 20.02M | -74.21M |
| Operating Cash Flow | 51.43M | -51.60M | 38.81M | -53.25M | 21.50M | -34.05M |
| Investing Cash Flow | 569.00K | 1.42M | 488.76K | 1.68M | 5.82M | -35.80M |
| Financing Cash Flow | -52.01M | 49.82M | -39.82M | 52.00M | -51.44M | 86.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹4.76B | 15.16 | ― | 1.49% | 14.78% | 19.77% | |
65 Neutral | ₹2.44B | 14.07 | ― | 0.40% | 1.59% | -15.40% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | ₹2.25B | -45.38 | ― | ― | 7.61% | -50.76% | |
44 Neutral | ₹4.09B | -229.02 | ― | 0.22% | -19.06% | -175.93% | |
42 Neutral | ₹142.85M | -9.71 | ― | ― | -100.00% | -54.11% |
Tijaria Polypipes Limited has disclosed that Bank of India has filed a case against the company before the National Company Law Tribunal (Jaipur), which has been registered as IA No. 491/JPR/2025. The matter is scheduled to be listed on 13 March 2026, and the company has informed the stock exchanges of this development in compliance with disclosure regulations, signaling potential legal and financial implications that stakeholders will monitor.
The disclosure underlines ongoing judicial proceedings that could affect Tijaria Polypipes Limited’s operations or capital structure, depending on the outcome at the NCLT. While the company has not provided further details on the nature or quantum of the claim, the involvement of a major lender and the NCLT forum suggests that investors and creditors will closely track the case’s progress and any subsequent resolutions or restructuring moves.